Lumira Ventures Closes on US$255 Million of New Capital to Build Transformative Healthcare Companies

TORONTO, MONTREAL, VANCOUVER, BC and BOSTON, July 26, 2021 /CNW/ - Lumira Ventures today announced a significant expansion of its capital base to support the founding and building of innovative healthcare companies in Canada and the U.S. The closing of the oversubscribed Lumira Ventures IV at US$220 million represents the largest fund Lumira has raised to date, and the largest institutional life sciences venture capital fund ever raised in Canada. In parallel, Lumira closed a strategic venture fund in partnership with an international pharmaceutical company. Collectively, the new funds represent over US$255 million (C$321 million) of committed capital.

NewsCatherine LamontagneJuly 26, 2021Lumira, Venture Capital, investment

Fonds de solidarité FTQ Invest US$17.7 Million in Lumira IV Life Sciences Fund

MONTRÉAL, Feb. 4, 2021 /CNW Telbec/ - As part of its strategy to support Québec's life sciences sector through well-performing specialized funds, the Fonds de solidarité FTQ ("Fonds") is investing US$17.7 million (C$22.5 million) in Lumira IV. Over the years, Lumira has invested in Québec companies such as enGene, Kisoji, Opsens and IMV.

NewsGuest UserFebruary 4, 2021Fonds FTQ, Lumira, Investment